Evidence map›Paper›PMID 22111864›Full record

ArticleChemical research in toxicology2012

Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity.

Christopher J Rivet, Yuan Yuan, Diana-Andra Borca-Tasciuc, Ryan J Gilbert

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 77 citations in OpenAlex.

  1. Nanomedicine in the treatment of Alzheimer's disease: bypassing the blood-brain barrier with cutting-edge nanotechnology.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Donors for nerve transplantation in craniofacial soft tissue injuries.Frontiers in bioengineering and biotechnology · 2022
    Review
  8. Toxicological Aspects of Iron Oxide Nanoparticles.Advances in experimental medicine and biology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher J RivetCenter for Biotechnology and Interdisciplinary Studies, Department of Biomedical Engineering, Rensselaer Polytechnic Institute , Troy, New York 12180-3590, United States.
Yuan Yuan
Diana-Andra Borca-Tasciuc
Ryan J Gilbert
Rensselaer Polytechnic Institute · US

Funding

Development of Biomaterials that Release Therapeutic Agents to Modulate InflammatR21NS062392 · NINDS · RENSSELAER POLYTECHNIC INSTITUTE · PI GILBERT, RYAN J. · 2009 to 2010
$389k
Acute Phase Treatment of Spinal Cord Injury Using Hydrogel Blends Loaded with GluR15HD061096 · NICHD · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI GILBERT, RYAN J. · 2009 to 2009
$234k
NICHD NIH HHS R15 HD061096NINDS NIH HHS R21 NS062392NINDS NIH HHS R21NS62392
6 · The paper itself

Abstract

Superparamagnetic iron oxide nanoparticles, with diameters in the range of a few tens of nanometers, display the ability to cross the blood-brain barrier and are envisioned as diagnostic and therapeutic tools in neuro-medicine. However, despite the numerous applications being explored, insufficient information is available on their potential toxic effect on neurons. While iron oxide has been shown to pose a decreased risk of toxicity, surface functionalization, often employed for targeted delivery, can significantly alter the biological response. This aspect is addressed in the present study, which investigates the response of primary cortical neurons to iron oxide nanoparticles with coatings frequently used in biomedical applications: aminosilane, dextran, and polydimethylamine. Prior to administering the particles to neuronal cultures, each particle type was thoroughly characterized to assess the (1) size of individual nanoparticles, (2) concentration of the particles in solution, and (3) agglomeration size and morphology. Culture results show that polydimethylamine functionalized nanoparticles induce cell death at all concentrations tested by swift and complete removal of the plasma membrane. Aminosilane coated particles affected metabolic activity only at higher concentrations while leaving the membrane intact, and dextran-coated nanoparticles partially altered viability at higher concentrations. These findings suggest that nanoparticle characterization and primary cell-based cytotoxicity evaluation should be completed prior to applying nanomaterials to the nervous system.

Indexed as

AnimalsCell MembraneCells, CulturedCell SurvivalChick EmbryoFerric CompoundsMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionNanoparticlesNeuronsParticle SizeProsencephalonSurface PropertiesX-Ray DiffractionFerric Compoundsferric oxide

Identifiers

PMID22111864
PMCPMC4183191
OpenAlexW2059002480

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.